Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Equity Bottom-Up

<ul style="list-style-type: disc;"><li>Key milestone in FDA approval. On October 6, Marizyme, Inc. (MRZM) announced a key milestone in its growth strategy, with FDA approval of its flagship DuraGraft (DG) technology for the US market.</li><li>Improved outcomes when used in cardiac care. DG has been proven to result in significantly improved outcomes and lower costs for cardiac surgery through multiple clinical trials as well as utilization in selected markets in Europe and Asia where adoption has recently accelerated.</li><li>Reflecting that, YTD DG-driven revenue is already more than double the level of 2022.</li></ul>

Key milestone in FDA approval. On October 6, Marizyme, Inc. (MRZM) announced a key milestone in its growth strategy, with FDA approval of its flagship DuraGraft (DG) technology for the US market.Improved outcomes when used in cardiac care. DG has been proven to result in significantly improved outcomes and lower costs for cardiac surgery through multiple clinical trials as well as utilization in selected markets in Europe and Asia where adoption has recently accelerated.Reflecting that, YTD DG-driven revenue is already more than double the level of 2022.

Marizyme, Inc. - DuraGraft Approved for US Markets

<ul style="list-style-type: disc;"><li>Marizyme, Inc. (MRZM) is a fast-growing biomedical company with a powerful multi-technology platform.</li><li>At the forefront is DuraGraft (DG), which has already demonstrated improved outcomes and lower costs for cardiac care through clinical trials and actual implementation in select overseas markets.</li><li>In addition to continued ‘OUS’ expansion, MRZM is readying for the implementation of DG in US markets, pending FDA approval.</li></ul>

Marizyme, Inc. (MRZM) is a fast-growing biomedical company with a powerful multi-technology platform.At the forefront is DuraGraft (DG), which has already demonstrated improved outcomes and lower costs for cardiac care through clinical trials and actual implementation in select overseas markets.In addition to continued ‘OUS’ expansion, MRZM is readying for the implementation of DG in US markets, pending FDA approval.

Marizyme, Inc. - Powerful Technology Platform Driving Strong Growth Potential

United States

Marizyme Inc operates as a holding company. THe Company, through its subsidiaries, engages in the software development and technology consulting businesses. Marizyme serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Marizyme (MRZM US)

Marizyme, Inc. - DuraGraft Approved for US Markets

On October 6, Marizyme, Inc. (MRZM) announced a key milestone in its growth strategy, with FDA approval of its flagship DuraGraft (DG) technology...

Water Tower Research

Marizyme, Inc. - Powerful Technology Platform Driving Strong Growth Potential

Marizyme, Inc. (MRZM) is a fast-growing biomedical company with a powerful multi-technology platform. At the forefront is DuraGraft (DG), which has...

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)